Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00587) | |||||
---|---|---|---|---|---|
Name |
Repaglinide
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Repaglinide; 135062-02-1; Prandin; NovoNorm; GlucoNorm; AG-EE 623 ZW; Repaglinidum [INN-Latin]; Repaglinida [INN-Spanish]; AG-EE 388 ZW; AGEE-623ZW; C27H36N2O4; UNII-668Z8C33LU; CHEMBL1272; AG-EE-388 ZW; CHEBI:8805; 668Z8C33LU; MFCD00906179; NCGC00016978-01; Repaglinida; Repaglinidum; CAS-135062-02-1; Actulin; Surepost; Reglin; SMR000466305; Prandin (TN); AG-EE 623ZW; Repaglinide (JAN/USP/INN); AG-EE-623 ZW; AG-EE-388; Repaglinide,(S); A10BX02; SMP-508; Surepost (TN); 135969-54-9; Repaglinide [USAN:USP:INN:BAN]; NN-623; 111GE012; Prestwick0_001046; Prestwick1_001046; Prestwick2_001046; Prestwick3_001046; DSSTox_CID_3552; DSSTox_RID_77078; DSSTox_GSID_23552; SCHEMBL16137; BSPBio_000972; MLS000759407; MLS001076684; MLS001424111; MLS006011560; AG-EE-623ZW; BIDD:GT0338; SPBio_002906; AG-EE-623-ZW; BPBio1_001070; GTPL6841; DTXSID3023552; HMS1571A14; HMS2051N08; HMS2094C07; HMS2098A14; HMS2231M21; HMS3414D09; HMS3678D09; HMS3715A14; Pharmakon1600-01506035; BCP04250; ZINC3798537; Tox21_110721; AC-726; ANW-63956; BDBM50153520; NSC759893; STK629501; AKOS005561792; Repaglinide, >=98% (HPLC), solid; BS-1010; CCG-101013; CS-0979; DB00912; MCULE-3611790330; NC00263; NSC-759893; NCGC00016978-02; NCGC00016978-04; NCGC00016978-05; HY-15209; SBI-0206942.P001; AB0013959; AB00514019; AM20090697; SW197344-4; 62R021; C07670; D00594; W-5210; AB00514019-09; AB00514019_10; AB00514019_11; SR-01000759404; Q-201663; Q2195995; SR-01000759404-4; BRD-K82846253-001-03-0; Z1777729210; Repaglinide, European Pharmacopoeia (EP) Reference Standard; Repaglinide, United States Pharmacopeia (USP) Reference Standard
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Diabetes mellitus | ICD-11: 5A10 | [1] | ||
PubChem CID | |||||
Formula |
C27H36N2O4
|
||||
Canonical SMILES |
CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
|
||||
InChI |
1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1
|
||||
InChIKey |
FAEKWTJYAYMJKF-QHCPKHFHSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=65981"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 452.6 | Topological Polar Surface Area | 78.9 | |
XlogP | 5.2 | Complexity | 619 | ||
Heavy Atom Count | 33 | Rotatable Bond Count | 10 | ||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Repaglinide 2 mg tablet | Click to Show/Hide the Full List of Formulation(s): 11 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Polacrilin potassium; Povidone, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Meglumine; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avera McKennan Hospital; Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [3] | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide red; Glycerin; Poloxamer 407; Silicon dioxide; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Paddock Laboratories, | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 407 | DIG Info | Albendazole monooxygenase (EC50 = 32.8 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide red; Glycerin; Poloxamer 188; Povidone; Cellulose, microcrystalline; Polacrilin potassium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Citron Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide red; Glycerin; Poloxamer 188; Povidone; Microcrystalline cellulose; Polacrilin potassium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aurobindo Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide red; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Poloxamer 181; Povidone, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Ferric oxide red; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Gemini Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Ferric oxide red; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | AvKARE; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Ferric oxide red; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Gemini Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Ferric oxide yellow; Glycerin; Talc; Poloxamer 188; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide red; Poloxamer 407; Povidone k30; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Breckenridge Pharmaceutical; Golden State Medical Supply | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Poloxamer 407 | DIG Info | Albendazole monooxygenase (EC50 = 32.8 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Repaglinide 1 mg tablet | Click to Show/Hide the Full List of Formulation(s): 11 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Fd&c blue no. 1; Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Polacrilin potassium; Povidone, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Fd&c blue no. 1; Magnesium stearate; Meglumine; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [2] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide yellow; Glycerin; Poloxamer 407; Silicon dioxide; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Paddock Laboratories, | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 407 | DIG Info | Albendazole monooxygenase (EC50 = 32.8 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide yellow; Glycerin; Poloxamer 188; Povidone; Cellulose, microcrystalline; Polacrilin potassium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Citron Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide yellow; Glycerin; Poloxamer 188; Povidone; Microcrystalline cellulose; Polacrilin potassium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aurobindo Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide yellow; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Poloxamer 181; Povidone, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Ferric oxide yellow; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | AvKARE; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Ferric oxide yellow; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Gemini Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Ferric oxide yellow; Glycerin; Talc; Poloxamer 188; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Ferric oxide red; 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)); Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Poloxamer 124; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Ferric oxide yellow; Poloxamer 407; Povidone k30; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Breckenridge Pharmaceutical; Golden State Medical Supply | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Poloxamer 407 | DIG Info | Albendazole monooxygenase (EC50 = 32.8 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Repaglinide 0.5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Polacrilin potassium; Povidone, unspecified; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Magnesium stearate; Meglumine; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Glycerin; Poloxamer 407; Silicon dioxide; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Paddock Laboratories, | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 407 | DIG Info | Albendazole monooxygenase (EC50 = 32.8 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Glycerin; Poloxamer 188; Povidone; Cellulose, microcrystalline; Polacrilin potassium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Citron Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Glycerin; Poloxamer 188; Povidone; Microcrystalline cellulose; Polacrilin potassium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aurobindo Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Glycerol formal; Povidone; Cellulose, microcrystalline; Polacrilin potassium; Poloxamer 124; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Meglumine; Glycerin; Talc; Poloxamer 188; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Meglumine | DIG Info | Alglucerase (IC50 = 447000 nM) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Poloxamer 407; Povidone k30; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Breckenridge Pharmaceutical; Golden State Medical Supply | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Poloxamer 407 | DIG Info | Albendazole monooxygenase (EC50 = 32.8 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.